Trial Profile
Efficacy and safety of Golimumab and predictors of treatment discontinuation in Japanese patients with Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Aug 2016
Price :
$35
*
At a glance
- Drugs Golimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 16 Aug 2016 New trial record